PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Bark extract (Nexrutine®) was tolerated in patients undergoing surgery or radiation; 81% of patients showed a decline in prostate-specific antigen [PMID:25205619]
Lipid-lowering and insulin-resistance improving actions of berberine (found in P. amurense) have been demonstrated in numerous randomized clinical trials [PMID:27671811]
Evidence summary
PubMed sources
- 1.PMID: 27671811 (2016) — Berberine and Its Role in Chronic Disease. · Advances in experimental medicine and biology
- 2.PMID: 39612339 (2024) — Convergent evolution of berberine biosynthesis. · Science advances
- 3.PMID: 31057654 (2019) — Phellodendri Cortex: A Phytochemical, Pharmacological, and Pharmacokinetic Review. · Evidence-based complementary and alternative medicine : eCAM
- 4.PMID: 35629433 (2022) — Antiproliferative Effect of Phellodendron amurense Rupr. Based on Angiogenesis. · Life (Basel, Switzerland)
- 5.PMID: 41518482 (2026) — Phellodendron amurense Rupr. Polysaccharides protects against diabetic nephropathy via alteration of PI3K/GSK-3β/Nrf2/TGF-β/Smad signaling pathway and gut microbiota.